Navigation Links
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BioCentury-Thomson Financial Investment Conference
Date:9/4/2007

ROCKVILLE, Md., Sept. 4 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) announced today that its presentation at the BioCentury - Thomson Financial 14th Anniversary NewsMakers in the Biotech Industry Conference will be webcast and may be accessed at http://www.hgsi.com .

(Logo: http://www.newscom.com/cgi-bin/prnh/20010612/HGSLOGO )

A member of Human Genome Sciences' senior management team will present an overview of the company on Thursday, September 6, 2007 at 3:30 pm Eastern Time.

Investors interested in listening to the live webcast should log on before the start time in order to download any software required. The archive of the webcast will be available for several days after the live event.

The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs.

HGS and Human Genome Sciences are registered trademarks of Human Genome Sciences, Inc. For additional information on Human Genome Sciences, Inc., visit the company's web site at http://www.hgsi.com .


'/>"/>
SOURCE Human Genome Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Human Primary Preadipocytes and Differentiated Adipocytes
2. Low Abundance cDNA Cloned Using Stratagenes Human Universal cDNA Library
3. Control RT-PCR Primers for Human Gene Transcripts with Varying Abundance
4. New Mammalian Expression Vectors Employ Stable, High-Level Fluorescence Humanized Renilla GFP Reporter
5. Human Universal cDNA Library Array I
6. Map and Link Human Genetic Disorders with SSLP Analysis
7. RT-PCR Primer Sets for Human and Mouse Mismatch Repair Genes
8. Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells
9. Fluorescence-Based Single-Tube Assays to Rapidly Detect Human Gene Mutations
10. Improve Lipid- or Calcium Phosphate-Mediated Transfection of Human Dermal Fibroblasts
11. Sequence-Validated and Expression-Tested Human cDNA in a Dual Expression Vector

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2009)...Sussex, U.K. and CLEVELAND, Nov. 18 /PRNewswire/ -...business and premier provider of diagnostic system...s, has expanded its East Grinstead, U.K., manufact...t increasing global demand for its Sensititre®...on testing. The expanded facility has been fully v...
(Date:11/18/2009)...18 /PRNewswire-FirstCall/ - YM BioSciences Inc. (N... development company that identifies and advances ...oducts at various stages of development, announced...were presented today in a poster at the 2009 AACR-...s conference in Boston, Massachusetts. The reporte...
(Date:11/18/2009)...., Nov. 18 Algenol Biofuels LLC, d...nd the technology group The Linde Group have agr...in order to identify the optimum management of car...ique algae and photobioreactor technology. This co...velop cost-efficient technologies that capture, st...
(Date:11/18/2009)...and HANGZHOU, China, Nov. 18 /PRNewswire-FirstCall...Company") (OTC Bulletin Board: NIUS), a leading U.... selling nutritional products for children, today ...oducts will be distributed in Shanghai, the larges...e year distribution contract with Hainan Qi Zheng ...
Breaking Biology Technology:TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 2TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 3TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 4YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING 2YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING 3Algenol Biofuels and The Linde Group Agree To Cooperate in CO2 and O2 Management For Biofuel Production From Algae 2Algenol Biofuels and The Linde Group Agree To Cooperate in CO2 and O2 Management For Biofuel Production From Algae 3Niusule Expands Geographic Footprint in China 2Niusule Expands Geographic Footprint in China 3
...ce to $0.64 - $0.67 from Prior Range of ... EPS Guidance of $0.90 - $1.10 for 2009 and $1.50 ...PITTSBURGH, Oct. 30 Mylan Inc. (NYSE: MYL ),toda...d nine months ended,Sept. 30, 2008., Financial Hi....52 for the three and nine,months ended Sept. 30, ...
...Inc. (Nasdaq:,INSM), a developer of follow-on biol...ts for the third quarter and nine-months ended Sep... Follow-on Biologics Program -- Received app... Healthcare products Regulatory Agency to init...pany,s second follow-on biologic ("FOB") ...
...oratories Inc., a,specialty pharmaceutical and dia...nd Trademark Office (USPTO) has issued two separat...) Thiopurine Metabolites, a,diagnostic test that e...iopurines to reach and maintain desired therapeuti...he claims in U.S. Patent Nos. 7,425,546 and,7,429,...
Other Biology Technology:Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008 2Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008 3Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008 4Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008 5Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008 6Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008 7Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008 8Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008 9Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008 10Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008 11Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008 12Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008 13Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008 14Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008 2Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008 3Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008 4Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008 5Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008 6Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008 7Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008 8Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008 9Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008 10Prometheus Strengthens Intellectual Property Portfolio with Newly Issued Patents for Thiopurine Metabolite Testing 2
(Date:11/19/2009)...ists are revealing the genetic instructions inside... maize, has one of the most complex sequences of D...ison genomicist David Schwartz, who was one of mor...Science . , "The maize genome is a true maze fu...oubled would-be sequencers for years," says Schwar...
(Date:11/19/2009)... 1 = more than 2: The offspring of two inbred stra...Characterizing the gene-level variability that lea...d vigor, could boost our ability to custom-tailor ...ntent for human consumption or high glucose conten...released DNA sequence of the common corn strain B7...
(Date:11/19/2009)...etic diversity in maize, also known as corn, resea...gene map that should pave the way to significant i...ood, fuel, animal feed and fiber around the world.... as a haplotype map, charts genetic diversity and ... of maize. The research team, led by U.S. Departme...
Breaking Biology News(10 mins):Sweet corn story begins in UW-Madison lab 2Sweet corn story begins in UW-Madison lab 3U of M plant scientist uncovers clues to yield-boosting quirks of corn genome 2University Medical Pharmaceuticals Selects Jeffrey Ten as Senior Vice President International Sales 5593 1University Medical Pharmaceuticals Selects Jeffrey Ten as Senior Vice President International Sales 5593 2University Medical Pharmaceuticals Selects Jeffrey Ten as Senior Vice President International Sales 5593 3BrainCells Inc Broadens Scientific Advisory Board Adding Drs Edward Scolnick and David Holtzman 5590 1BrainCells Inc Broadens Scientific Advisory Board Adding Drs Edward Scolnick and David Holtzman 5590 2BrainCells Inc Broadens Scientific Advisory Board Adding Drs Edward Scolnick and David Holtzman 5590 3Enhanced Food Safety and Systems Interoperability the Themes of Food Traceability Interoperability Summit 2010 5587 1Enhanced Food Safety and Systems Interoperability the Themes of Food Traceability Interoperability Summit 2010 5587 2
...ns when no medical necessity exists - Florida, Ne...ington, Florida increase most , The number of pre...sarean section (C-section) rose by 36.6 percent fr...ay by HealthGrades, the leading provider of indepe...e variation from state to state in the rate of the...
...al waste, placental tissue could feasibly provide ...l to treat diseases and regenerate tissues as thei...cells, suggests a University of Pittsburgh study t...able now as an early online publication in Stem Ce...mnion, or the outer membrane of the amniotic sac, ...
... the risk of mother-to-child transmission of hepat...ublished in the December 1 issue of The Journal of... study found that infant girls are twice as likely...ide new information with which to counsel pregnant...new studies expand upon preliminary data from smal...
Other Biology News:'Patient-choice' C-section rate rises 36%: HealthGrades study 2'Patient-choice' C-section rate rises 36%: HealthGrades study 3Discarded placentas deliver researchers promising cells similar to embryonic stem cells 2Discarded placentas deliver researchers promising cells similar to embryonic stem cells 3Discarded placentas deliver researchers promising cells similar to embryonic stem cells 4Studies clarify risk factors for mother-to-child transmission of hepatitis C virus 2
...Kit contains all reagents necessary to efficiently...tic lineage, as determined by staining for mineral...essary reagents and a protocol for quantifying ost...uct is useful for studying the effects of growth f...
...arch: Developed for a wide range of bioanalytical ... in Luminescence Spectroscopy • Automated acc...ic gratings for reduced stray light • Versati...non lamp reduces photo bleaching • Large conv...
...tent-pending Formula Predictor software takes adva... pattern verification, and unique fragment-ion fil...ect formula for unknown components. Traditional ...ss spec data often depend on very high mass accura...
PerkinElmer Spectrum Beer's Law QUANT Quantitative Software, Floppy Disk from PerkinElmer
Biology Products: